jRCTs031200397: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Preventive Effect of Naldemedine on Opioid-Induced Constipation |
|
|
| Completed | N/A | 100 | Japan | Symproic (naldemedine) - Shionogi, Collegium Pharma | University of Tsukuba Hospital, Japanese Society for Palliative Medicine | Neoplasms | | | | |
NCT03720613: Risk of Major Adverse Cardiovascular Events for Naldemedine and Other Medications for Opioid Induced Constipation in Adults With Chronic Non-Cancer Pain |
|
|
| Recruiting | N/A | 34532 | US | Naldemedine, Symproic®, Lubiprostone, Amitiza®, Naloxegol, Movantik® | BioDelivery Sciences International, HealthCore, Inc. | Opioid-induced Constipation | 11/30 | 11/30 | | |
